Recent Updates
Recently added Catalysts
TMDX Positive Sentiment Score: 85/100

TransMedics to Participate in the 42nd Annual J.P. Morgan Healthcare Conference TransMedics Group, Inc. ( TransMedics ) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with...

Monday, December 18, 2023 2 min read
Key Takeaway: TransMedics Group, Inc. will participate in the 42nd Annual J.P. Morgan Healthcare Conference on January 8, 2024. The management team is expected to present the company's advancements in organ transplant therapy, particularly for end-stage heart, lung, and liver failure. This conference is an important platform for healthcare companies to connect with investors and stakeholders, potentially leading to increased visibility and support for TransMedics’ innovations in portable organ perfusion technology.

Market Sentiment Analysis

POSITIVE FACTORS

  • TransMedics is participating in a prominent healthcare conference.
  • The company is recognized as a leader in organ transplant technology.
  • Their innovations aim to improve organ quality and utilization.
  • The presentation could enhance visibility and investor interest.

Full Press Release Details

ANDOVER, Mass. , Dec. 18, 2023 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX ), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced that members of the management team will present at the upcoming 42 nd Annual J.P. Morgan Healthcare Conference. The presentation will take place on Monday, January 8, 2024 , at 3:00 p.m. Pacific Standard Time / 6:00 p.m. Eastern Standard Time .
Event: 42 nd Annual J.P. Morgan Healthcare Conference Date: Monday, January 8, 2024 Time: 3:00 p.m. PST
A live and archived webcast of the presentation will be available on the "Investors" section of the TransMedics website at https://investors.transmedics.com/ .
About TransMedics Group, Inc. TransMedics is the world's leader in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Headquartered in Andover, Massachusetts , the company was founded to address the unmet need for more and better organs for transplantation and has developed technologies to preserve organ quality, assess organ viability prior to transplant, and potentially increase the utilization of donor organs for the treatment of end-stage heart, lung, and liver failure.
Investor Contact: Brian Johnston 332-895-3222 [email protected]
SOURCE TransMedics Group, Inc.

21 %

Frequently Asked Questions

When will TransMedics present at the J.P. Morgan Healthcare Conference?

TransMedics will present at the conference on January 8, 2024, at 3:00 p.m. PST.

How can I watch the TransMedics presentation?

The presentation will be available via live and archived webcast on their website.

What does TransMedics specialize in?

TransMedics focuses on transforming organ transplant therapy for end-stage organ failure.

Where is TransMedics Group, Inc. headquartered?

TransMedics is headquartered in Andover, Massachusetts.

Tags: TMDX Viatris Investor Conferences Healthcare TransMedics healthcare conference organ transplantation medical technology
Last updated: Dec 18, 2023